ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Long-Term Outcomes After Pediatric Liver Transplantation for Malignant Liver Tumors: Effects of Era and Age.

    R. Patel,1 I. Feurer,1 S. Karp,1 L. Gillis,1 H. Katzenstein,1 H. Lovvorn III,1 J. Pietsch,1 D. Chung, G. Tiao,2 D. Hanto.1

    1Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN; 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

    Background: Hepatoblastoma (HB), hepatocellular carcinoma (HCC), along with hemangioendothelioma, hemangiosarcoma, and angiosarcoma (HHA) are rare tumors in children that are treated with orthotopic liver transplantation…
  • 2016 American Transplant Congress

    Barriers to Comprehensive Transplant Education at U.S. For-Profit Dialysis Centers and Associations with Waitlist Access.

    A. Waterman,1 J. Peipert,1 H. Xiao,2 C. Goalby,1 K. Lentine.2

    1UCLA, Los Angeles, CA; 2St. Louis Univ., St. Louis, MO.

    The Centers for Medicare and Medicaid Services (CMS) requires that dialysis patients be informed of their transplant options. Compared to non-profit dialysis centers, for-profit centers…
  • 2016 American Transplant Congress

    Improving the Efficiency, Safety and Cost of Evaluating Living Donor Liver Candidates Using Single Sequence MRI.

    M. Schilsky,1,2 K. Cartiera,1 S. Boga,1 S. Schilsky,3 S. Emre,1 D. Mulligan,1 J. Weinreb,1 G. Israel.1

    1Yale New Haven Transplantation Center, Transplantation and Immunology, Surgery, Yale University, New Haven, CT; 2Section of Digestive Diseases, Medicine, Yale University, New Haven, CT; 3Food and Drug Administration, Silver Springs, MD.

    Background: Current evaluation of donor candidates for adult-to-adult living donor liver transplant (LDLT) includes MRI and CT without and with contrast for defining liver anatomy.…
  • 2016 American Transplant Congress

    Antibody-Mediated Rejection in Pancreas Transplantation.

    O. Serrano,1 D. Vock,2 E. Finger,1 R. Kandaswamy,1 D. Sutherland,1 T. Dunn.1

    1Surgery, Univ. of Minnesota, Minneapolis, MN; 2Biostatistics, University of Minnesota, Minneapolis, MN.

    PURPOSE: The diagnostic criteria for antibody-mediated rejection (AMR) in pancreas transplantation (PTx) is evolving. The incidence and long-term effect of AMR have not been well-described.…
  • 2016 American Transplant Congress

    Surveillance Renal Allograft Biopsies Prognosticate Graft Function.

    J. Thompson, D. Taber, P. Baliga, K. Chavin, T. Srinivas.

    MUSC, Charleston, SC.

    Background: Surveillance biopsy of the renal allograft provides a window into the health of the allograft and could allow prognostication of function by affording better…
  • 2016 American Transplant Congress

    Early Hospital Readmission Following Kidney Re-Transplantation.

    E. King, B. Orandi, S. Bae, X. Luo, D. Segev.

    Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD.

    BACKGROUND: Among first time kideny transplant (KT) recipients the incidence of early hospital readmission (EHR) is 31%. Kidney re-transplants are more complex and we hypothesize…
  • 2016 American Transplant Congress

    Predicting Obstructive Coronary Artery Disease in Asymptomatic Patients Undergoing Renal Transplantation Using a Simple Risk Score.

    D. Moutzouris, C. Baker, M. Willicombe, N. Duncan, J. Galliford, A. McLean, D. Taube.

    Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London, United Kingdom.

    PurposeCoronary angiography in asymptomatic patients with End Stage Renal Disease (ESRD) shows significant Coronary Artery Disease (CAD) (stenosis >50%) in 37-53% of patients. We have…
  • 2016 American Transplant Congress

    Tolerance Induction with Donor Bone Marrow Transplantation in Kidney Transplantation.

    H. Park,1 N. Lee,1 S. Lee,1 G. Choi,1 C. Kwon,1 S. Kim,1 J.-W. Joh,1 M. Kim,2 Y. Kwon,2 S.-K. Lee.1

    1Department of Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea; 2Transplantation Research Center, Samsung Biomedical Research Institute, Seoul, Republic of Korea.

    Tolerance induction is considered to be a final goal in the field of organ transplantation. We have performed simultaneous bone marrow and kidney transplantation in…
  • 2016 American Transplant Congress

    Factors Associated with Mortality Among a Large Population of Patients with Cirrhosis and a Low MELD (<15).

    K. Atiemo, L. Zhao, A. Skaro, L. VanWagner, S. Goel, A. Kho, B. Ho, R. Kang, S. Montag, J. Holl, M. Abecassis, D. Ladner.

    Northwestern University, Chicago.

    AimStudies suggest that certain patients with liver cirrhosis and a low MELD score (<15) remain at high risk for mortality. Current data is largely limited…
  • 2016 American Transplant Congress

    Erythropoietin (EPO) Mediates Spontaneous Kidney Transplant Tolerance in Mice.

    P. Cravedi,1 C. Purroy,1 J. Madsen,2 R. Fairchild,3 T. Tanaka,3 W. Baldwin 3rd,3 A. Alessandrini,2 P. Heeger.1

    11Icahn School of Medicine at Mount Sinai, New York, NY; 2Transplantation Biology Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA; 33Department of Immunology, Cleveland Clinic Foundation, Cleveland.

    Spontaneous allogeneic kidney transplant tolerance occurs in mice, but the underlying mechanisms are unknown. Building upon recent human data showing that EPO, an erythropoietic hormone…
  • « Previous Page
  • 1
  • …
  • 109
  • 110
  • 111
  • 112
  • 113
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences